Literature DB >> 17553539

Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells.

Matloob Husain1, Andrea S Weisberg, Bernard Moss.   

Abstract

The extracellular form of vaccinia virus is referred to as an enveloped virion (EV) because it contains an additional lipoprotein membrane surrounding the infectious mature virion (MV) that must be discarded prior to cell fusion and entry. Most EVs adhere to the surface of the parent cell and mediate spread of the infection to adjacent cells. Here we show that some attached EVs have ruptured envelopes. Rupture was detected by fluorescence microscopy of unfixed and unpermeabilized cells using antibodies to the F13 and L1 proteins, which line the inner side of the EV membrane and the outer side of the MV membrane, respectively. The presence of ruptured EV membranes was confirmed by immunogold transmission electron microscopy. EVs with broken membranes were present on several cell lines examined including one deficient in glycosaminoglycans, which are thought to play a role in breakage of the EV membrane prior to fusion of the MV. No correlation was found between EVs with ruptured membranes and actin tail formation. Studies with several mutant viruses indicated that EV membranes lacking the A34 protein were unbroken. This result was consistent with other properties of A34R deletion mutants including resistance of the EV membrane to polyanions, small plaque formation and low infectivity that can be increased by disruption of the EV membrane by freezing and thawing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553539      PMCID: PMC2048979          DOI: 10.1016/j.virol.2007.05.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  The formation and function of extracellular enveloped vaccinia virus.

Authors:  Geoffrey L Smith; Alain Vanderplasschen; Mansun Law
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

3.  The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion.

Authors:  Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Topology of epitope-tagged F13L protein, a major membrane component of extracellular vaccinia virions.

Authors:  Matloob Husain; Andrea Weisberg; Bernard Moss
Journal:  Virology       Date:  2003-04-10       Impact factor: 3.616

7.  Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene.

Authors:  Tatiana G Senkevich; Brian M Ward; Bernard Moss
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins.

Authors:  Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion.

Authors:  C M Sanderson; F Frischknecht; M Way; M Hollinshead; G L Smith
Journal:  J Gen Virol       Date:  1998-06       Impact factor: 3.891

10.  Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans.

Authors:  Gemma C Carter; Mansun Law; Michael Hollinshead; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2005-05       Impact factor: 3.891

View more
  10 in total

1.  The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.

Authors:  Amalia K Earley; Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

2.  Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.

Authors:  Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

3.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

4.  Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.

Authors:  Kim L Roberts; Adrien Breiman; Gemma C Carter; Helen A Ewles; Michael Hollinshead; Mansun Law; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

5.  Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.

Authors:  Timothy R Wagenaar; Suany Ojeda; Bernard Moss
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

6.  Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope.

Authors:  Beatriz Perdiguero; María M Lorenzo; Rafael Blasco
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture.

Authors:  Florian Ingo Schmidt; Christopher Karl Ernst Bleck; Ari Helenius; Jason Mercer
Journal:  EMBO J       Date:  2011-07-26       Impact factor: 11.598

8.  Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies.

Authors:  Delphine M Depierreux; Arwen F Altenburg; Lior Soday; Alice Fletcher-Etherington; Robin Antrobus; Brian J Ferguson; Michael P Weekes; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2022-06-21       Impact factor: 7.464

9.  A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.

Authors:  Ingo Jordan; Deborah Horn; Katrin John; Volker Sandig
Journal:  Viruses       Date:  2013-01-21       Impact factor: 5.048

Review 10.  Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Authors:  Ingo Jordan; Verena Lohr; Yvonne Genzel; Udo Reichl; Volker Sandig
Journal:  Microorganisms       Date:  2013-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.